Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Pinchevsky · SciRah

Researcher profile · Semantic Scholar

Y. Pinchevsky

Share profile

Y. Pinchevsky — researcher profile on SciRah

h-index: 7
Works: 15
Citations: 184

Most-cited papers

Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature
Y. Pinchevsky, N. Butkow, F. Raal, T. Chirwa +1 more
2020International Journal of General Medicine75 citations Open access
Semantic Scholar
Treatment Gaps Found in the Management of Type 2 Diabetes at a Community Health Centre in Johannesburg, South Africa
Y. Pinchevsky, N. Butkow, T. Chirwa, F. Raal
2017Journal of Diabetes Research25 citations Open access
Semantic Scholar
Glycaemic, blood pressure and cholesterol control in 25 629 diabetics
Y. Pinchevsky, N. Butkow, T. Chirwa, F. Raal
2015Cardiovascular Journal of Africa24 citations Open access
Semantic Scholar
The implementation of guidelines in a South African population with type 2 diabetes
Y. Pinchevsky, N. Butkow, F. Raal, T. Chirwa
201322 citations Open access
Semantic Scholar
The achievement of glycaemic, blood pressure and LDL cholesterol targets in patients with type 2 diabetes attending a South African tertiary hospital outpatient clinic
Y. Pinchevsky, V. Shukla, N. Butkow, F. Raal +1 more
201511 citations Open access
Semantic Scholar
Quality of care delivered to type 2 diabetes mellitus patients in public and private sector facilities in Johannesburg, South Africa
Y. Pinchevsky, F. Raal, N. Butkow, T. Chirwa +2 more
2018International Journal of General Medicine9 citations Open access
Semantic Scholar
International Journal of General Medicine Dovepress Multi-ethnic Differences in Hba 1c , Blood Pressure, and Low-density-lipid Cholesterol Control among South Africans Living with Type 2 Diabetes, after a 4-year Follow-up
Y. Pinchevsky, V. Shukla, N. Butkow, T. Chirwa +1 more
7 citations
Semantic Scholar
The public health and economic consequences of unintended pregnancies in South Africa
H. Le, M. Connolly, Jing-Bo Yu, Y. Pinchevsky +1 more
20156 citations Open access
Semantic Scholar
Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study
D. Brittain, S. Akhtar, S. Rodrigues, Moosa Patel +14 more
2024Turkish journal of haematology : official journal of Turkish Society of Haematology3 citations Open access
Semantic Scholar
The implementation of current guidelines regarding the treatment of cardiovascular risk in type 2 diabetics
Y. Pinchevsky
20121 citations
Semantic Scholar
PP01.52: MET Testing and Treatment Sequencing After Disease Progression on First-Line Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) and Acquired MET Overexpression and/or Amplification (OverExp/AMP): US Analysis of a Global R
J. Rotow, U. Malapelle, D. Cuadras, N. Lara +4 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
MET Testing and Treatment Sequencing After Disease Progression on First-Line Osimertinib in Patients With EGFR-Mutated Advanced NSCLC and Acquired MET Overexpression and/or Amplification: A Global Real-World Study.
J. Rotow, U. Malapelle, Daniel Cuadras, N. Lara +5 more
2026Clinical Lung Cancer0 citations
Semantic Scholar
24P A global physician based survey on biomarker testing in advanced NSCLC and treatment selection following MET-driven progression on 1L EGFR TKIs
L. Bonanno, D. Simmons, H. Bailey, H. Burlison +6 more
2026ESMO Open0 citations Open access
Semantic Scholar
1005P MET testing and treatment (tx) sequencing after progression of disease (PD) on first-line (1L) osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and acquired MET overexpression and/or amplification (OverExp/Amp): Final analysis of a global real-world (rw) study
J. Rotow, U. Malapelle, D. Cuadras, N. Lara +4 more
2025Annals of Oncology0 citations
Semantic Scholar
1967P MET testing and treatment (tx) sequencing after progression on first-line (1L) osimertinib (osi) in patients (pts) with EGFRm advanced NSCLC and acquired MET overexpression and/or amplification (OverExp/Amp): interim analysis of a global real-world (rw) study
J. Rotow, U. Malapelle, D. Cuadras, N. Lara +4 more
2025Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Butkow×6
Invite
N. Butkow — researcher profile on SciRah
T. Chirwa×5
Invite
T. Chirwa — researcher profile on SciRah
J. Rotow×4
Invite
J. Rotow — researcher profile on SciRah
U. Malapelle×4
Invite
U. Malapelle — researcher profile on SciRah

×3

Invite

F. Raal — researcher profile on SciRah

Invite

D. Cuadras — researcher profile on SciRah

Invite

Y. Kim — researcher profile on SciRah

Invite

F. Raal — researcher profile on SciRah

Invite

A. Rothberg — researcher profile on SciRah

Invite

T. Chirwa — researcher profile on SciRah

Invite

V. Shukla — researcher profile on SciRah

Invite

N. Lara — researcher profile on SciRah